Literature DB >> 8609781

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

P Kehoe, J Williams, S Lovestone, G Wilcock, M J Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8609781

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

3.  Clinical rationale of genetic testing in dementia.

Authors:  G B Frisoni; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

4.  Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.

Authors:  M Yasuda; N Hirono; K Maeda; T Imamura; E Mori; C Tanaka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

5.  No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a Tunisian population.

Authors:  Afef Achouri Rassas; Sondess Hadj Fredj; Hela Mrabet Khiari; Safa Sahnoun; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  J Neural Transm (Vienna)       Date:  2013-01-31       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.